Investigation of the Lactam Side Chain Length Necessary for Optimal Indenoisoquinoline Topoisomerase I Inhibition and Cytotoxicity in Human Cancer Cell Cultures
- 3 April 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (9), 2040-2048
- https://doi.org/10.1021/jm0613119
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Synthesis and Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Substituted with Nitrogen HeterocyclesJournal of Medicinal Chemistry, 2006
- Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assayBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis of benz[d]indeno[1,2-b]pyran-5,11-diones: Versatile intermediates for the design and synthesis of topoisomerase I inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Cellular Topoisomerase I Inhibition and Antiproliferative Activity by MJ-III-65 (NSC 706744), an Indenoisoquinoline Topoisomerase I PoisonMolecular Pharmacology, 2004
- Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Cellular roles of DNA topoisomerases: a molecular perspectiveNature Reviews Molecular Cell Biology, 2002
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- Synthesis of Cytotoxic Indenoisoquinoline Topoisomerase I PoisonsJournal of Medicinal Chemistry, 1999
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990